Mark R. Vandien, RPA

Mark Vandien practices at Glens Falls Hospital Inc in Queensb Ury, New York.

Mark Vandien's NPI, 1194951905, was assigned on June 8, 2009. Mark Vandien holds New York license 013357.

Mark Vandien's primary practice is Glens Falls Hospital Inc, at 6 Hearts Way, Queensb Ury, NY 12804 in Warren County. The practice phone is (518) 792-1233.

Mark Vandien's primary practice is Glens Falls Hospital Inc in Queensb Ury, New York. Mark Vandien is also affiliated with Albany Medical Center. The medical group on file is Glens Falls Hospital. Dmand AI also links Mark Vandien to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mark Vandien practices, 4 sites in all. Vendor and product names are available with a free account.

Physician assistant is Mark Vandien's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Mark Vandien is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Mark Vandien is licensed in New York.

Dmand AI lists muscle pain, fibromyalgia, and limb pain and tobacco use among the conditions Mark Vandien treats.

CMS data shows 403 Medicare services from Mark Vandien across 4 procedure codes in 2024, for 314 Medicare patients. Medicare paid $19,137 for them.

CMS counts 314 Medicare patients who saw Mark Vandien in 2024. The largest group is 75 to 84, with 132 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mark Vandien's median patient age at 71, with 40% women.

In 2024, Mark Vandien wrote 3,389 Medicare Part D claims for 1,160 patients. 78% of them were for generic drugs. CMS names the drug for 3,134 of them, across 41 drugs with 11 or more claims each, at $813,218 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Mark Vandien for performance year 2024, reported through an alternative payment model (APM). Mark Vandien accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 29 general payments to Mark Vandien from 13 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $114.